Management Options for Low-Risk Prostate Cancer
This report represents a summary of three prior technology appraisals of management options for clinically-localized, low-risk prostate cancer. Download this PDF to read the entire report.
What is the Role of Interstitial Brachytherapy?
“Recent technological advances have permitted the widespread use in the U.S. and Europe of transperineally placed radioisotopes under ultrasound guidance into the prostate for treatment of gland confined cancer.”
Incorporation of Electronic Brachytherapy for Skin Cancer
The introduction of an electronic brachytherapy delivery system into an existing general dermatology practice is described. Radiobiologic rational for the dose fractionation schedule is detailed.